mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.04 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
Vinblastine |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.05 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.05 |
mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
0.42 |
0.05 |